Author:
Fang Ming,Wu Xin-Chi,Huang Wenlong
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Biochemistry,General Medicine,Biophysics
Reference41 articles.
1. Hansdóttir, H. (2008). Raloxifene for older women: A review of the literature. Clinical Interventions in Aging, 3, 45–50.
2. Ko, S. S., & Jordan, V. C. (2011). Treatment of osteoporosis and reduction in risk of invasive breast cancer in postmenopausal women with raloxifene. Expert Opinion on Pharmacotherapy, 12, 657–674.
3. Ogita, H., Node, K., Asanuma, H., Sanada, S., Liao, Y., Takashima, S., et al. (2002). Amelioration of ischemia- and reperfusion-induced myocardial injury by the selective estrogen receptor modulator, raloxifene, in the canine heart. Journal of Cardiology, 39, 55–56.
4. Ogita, H., Node, K., Asanuma, H., Sanada, S., Kim, J., Takashima, S., et al. (2004). Raloxifene improves coronary perfusion, cardiac contractility, and myocardial metabolism in the ischemic heart: Role of phosphatidylinositol 3-kinase/Akt pathway. Journal of Cardiovascular Pharmacology, 43, 821–829.
5. Chin, M., Isono, M., Isshiki, K., Araki, S., Sugimoto, T., Guo, B., et al. (2005). Estrogen and raloxifene, a selective estrogen receptor modulator, ameliorate renal damage in db/db mice. American Journal of Pathology, 166, 1629–1636.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献